Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
27.9%
% of SBIO's 87 holdings also in CNCR
32.0%
% of CNCR's 75 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 3.1% | 1.5% | 1.5% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 1.9% | 1.3% | 1.3% |
 |
MERUS N.V. | 1.6% | 1.3% | 1.3% |
|
IDEAYA BIOSCIENCES, INC. | 2.0% | 1.2% | 1.2% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.3% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to CNCR
|
VIKING THERAPEUTICS, INC. | 5.3% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 4.8% |
|
VAXCYTE, INC. | 4.6% |
 |
ALKERMES PLC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 2.3% |
|
CRINETICS PHARMACEUTICALS INC | 2.1% |
|
XENON PHARMACEUTICALS INC. | 2.0% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.8% |
|
DENALI THERAPEUTICS INC. | 1.7% |
SBIO Underweight Relative to CNCR
|
ACRIVON THERAPEUTICS, INC. | -2.6% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
GERON CORP | -1.8% |
|
JANUX THERAPEUTICS, INC. | -1.8% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
2SEVENTY BIO, INC. | -1.6% |
|
IMMUNITYBIO INC | -1.5% |
|
MERCK & CO. INC. | -1.5% |
|
LYELL IMMUNOPHARMA, INC. | -1.4% |
|
Y-MABS THERAPEUTICS, INC. | -1.4% |